<?xml version="1.0" encoding="UTF-8"?>
<p id="p1140">
 <italic>Replication inhibitors</italic> targeting NS1, NS3 helicase, NS4A, NS4B, NS5 methyl transferase, and NS5 RdRp are being considered and many in vitro studies have proved their efficacy (
 <xref rid="bib1" ref-type="bibr">Abdel-Magid, 2017</xref>, 
 <xref rid="bib67" ref-type="bibr">da Costa et al., 2013</xref>, 
 <xref rid="bib250" ref-type="bibr">Pelliccia et al., 2017</xref>, 
 <xref rid="bib351" ref-type="bibr">Yeo et al., 2015</xref>).
</p>
